Amphastar Pharmaceuticals Inc at Jefferies Healthcare Conference Transcript
There we go. All right. Good afternoon, everybody. Thank you for joining us and braving the elements to be here. We're excited to have Amphastar Pharmaceuticals with us for our next presentation. Joining us from the company is the CFO, Bill Peters. He is right to my right. And Dan Dischner, the Senior Vice President of Corporate Communications to his right.
The time we have here is going to be used as a question-and-answer format. So -- but we have a microphone in the back. We love to -- I'm sure Bill and Dan will love to hear any questions you might have. We'll pass the mic forward if you could use it for the benefit of anybody on the webcast that would be helpful.
I'm Glen Santangelo. I'm the analyst at Jefferies obviously. I cover the specialty pharmaceutical sector as well as the healthcare information technology sector at Jefferies.
And before we get started, there's just one quick disclaimer that I need to read. I just wanted to note that on I'm sure many of you know, Amphastar recently announced a transaction and given our firm's
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
